1 ... 7 8 9 10 11 Showing 501 to 545 of 545 trials. Show trials.
 
Trial Name Trial ID Main Coordinating Centre
and contact
Status Recruitment Topic Participants Details
MOSAIC - GP cluster randomised trial to reduce partner violence among pregnant women and women with pre-school children ACTRN12607000010493/NHMRC 280617 Mother and Child Health Research, Vic a.taft@latrobe.edu.au Recruitment complete
A prospective, randomised, open label trial on the effect of metformin on in-vitro fertilisation outcome in women with polycystic ovary syndrome ACTRN12609000510246 Reproductive Medicine, Royal Hospital for Women, Barker St, Randwick 2031, NSW
juliette.koch@sesiahs.health.nsw.gov.au
Not yet recruiting
PIVOT - Parenteral intravenous optimal treatment for hypertensive emergencies in pregnancy PTO388 Annemarie Hennessy Recruitment complete
FICare - A Family Integrated Care model for the neonatal intensive care unit: a cluster randomised controlled trial NCT01852695 Mt Sinai Hospital, Canada k.lui@unsw.edu.au Currently recruiting
Comparative 12 month study of menstrually-signalled use of a combined contraceptive pill versus a combined contraceptive vaginal ring ACTRN12609000391279 Family Planning NSW (FPNSW), 328-336 Liverpool Road, Ashfield 2131 NSW
janeh@fpnsw.org.au
Currently recruiting
High flow support versus continuous positive airway pressure (CPAP) support in non-acute respiratory support for preterm infants from 30 weeks corrected gestation ACTRN12610000677000 Ashley McEwan: ashley.mcewan@hotmail.com Recruitment complete Newborn respiratory
HEPRIN - Heparin for the Prevention of complications related to placental Insufficiency ISRCTN88675588 Mt Sinai Hospital, Professor Jodie Dodd (Principal Investigator) jodie.dodd@adelaide.edu.u Recruitment complete Preeclampsia. Fetal growth Women with significant risk factors for placental insufficiency (low PAPP-A, high AFP, high inhibin, high hCG, medical and obstetric risk factors or abdnormal uterine artery Doppler)
Supervised home-based exercise may attenuate the decline of glucose tolerance in obese pregnant women Assoc/Prof Kym Guelfi Recruitment complete Obesity
A randomised controlled trial of continuous versus intermittent infusion of vancomycin in neonates NCT02210169 Murdoch Childrens Research Institute amanda.gwee@rch.org.au Currently recruiting
TIPPS - Thrombophilia in Pregnancy Prophylaxis Study: a multicentre, multinational, randomised controlled trial of prophylactic low molecular weight heparin in high-risk pregnant thrombophilic women ACTRN12608000446369 The Ottawa Hospital, Civic Campus, Civic Parkdale Clinic, 463-737 Parkdale Ave, Ottawa, Ontario K1Y 4E9
amclement@ohri.ca
Currently recruiting
Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and post-partum iron deficiency anaemia: a randomised trial Bernd Froessler Recruitment complete
e-prem - Improving child and parent outcomes after preterm birth using a web-based early intervention program ACTRN12614000906651 Murdoch Childrens Research Institute karli.treyvaud@mcri.edu.au Discontinued
Mirena Intra-Uterine System: Does it Improve Long Term Symptoms in Women with Chronic Pelvic Pain and/or Endometriosis after Laparoscopy? ACTRN12608000029392 Early Pregnancy, Gynaecological Ultrasound and Advanced Endoscopic Unit, Nepean Centre for Perinatal Care, Nepean Clinical School, Nepean Hospital, Penrith 2750, NSW
gcondous@hotmail.com
Currently recruiting
Effect of antireflux medication, placebo and infant mental health intervention on persistent crying: a randomized clinical trial Brigid Jordan Recruitment complete
NIFTY - A multi-centre randomised double blind placebo controlled trial of nifedipine maintenance tocolysis in fetal fibronectin positive women in threatened preterm labour ACTRN12613000985785 National Women's Health, Auckland Hospital. Dr Emma Parry (Principal Investigator) EmmaP@adhb.govt.nz Recruitment complete Preterm birth ? prevention and treatment Women with threatened preterm labour, a singleton pregnancy, gestational age between 24 and 34 weeks, intact membranes, positive fetal fibronectin test, completed course of corticosteroids
Randomised controlled trial of a decision aid for labour analgesia for primiparous women PT0534/ISRCTN52287533/NHMRC253635&262047 Camille Raynes-Greenow Recruitment complete
A pilot study on delivery suite mask ventilation in extremely preterm infants ACTRN12614000245695 Neonatal Intensive Care Unit; Westmead Hospital
dharmesh.shah@health.nsw.gov.au; mark.tracy@health.nsw.gov.au
Currently recruiting
DINO-II pilot study - Determining the docosahexaenoic acid dose to obtain plasma and erythrocyte phospholipid fatty acid profiles in preterm infants comparable to term infant profiles: a dose response pilot study. ACTRN12610000382077 carmel.collins@health.sa.gov.au Recruitment complete Newborn nutrition Infants born less than 33 weeks gestation after one but before five days of commencing any enteral feeds and with parental/guardian consent. Multiple births will be eligible and will be randomised individually. Women providing breast milk for their infant not taking DHA supplements or willing to stop taking supplements for duration study.
Prediction of normal vaginal delivery PT0547 Nepean Hospital Hans Peter Dietz Discontinued
Effectiveness of a modified mother-infant transaction program on outcomes for preterm infants from 3 to 24 months of age carol.newnham@austin.org.au Recruitment complete Parenting
Targeted Delivery Suite Intervention Study (TARDIS). A randomised controlled trial of modes of ventilatory support in preterm babies from point of delivery to the neonatal intensive care unit ACTRN12609000986279 Nepean Hospital mark.tracy@swahs.health.nsw.gov.au Currently recruiting Newborn respiratory
ACTS - Australasian Collaborative Trial of vitamin C and E supplementation for the prevention of pre-eclampsia ISRCTN00416244/NCT00097110/NHMRC207744 caroline.crowther@adelaide.edu.au Recruitment complete Preeclampsia. Maternal nutrition. Maternal medical conditions Nulliparous women with a singleton pregnancy, between 14-22 weeks gestation, a normal blood pressure
Epi-No Trial: Effect of intravaginal balloon device on levator trauma in mothers following childbirth ACTRN12609000592246 Nepean Hospital, NSW hans.dietz@sydney.edu.au Recruitment complete
USES Trial - Women's Opinions and Experiences of Prenatal Screening for Down Syndrome PT0355 caroline.crowther@adelaide.edu.au Recruitment complete Fetal surveillance. Fetal anomaly Women at less than 14 weeks gestation who have not had a dating scan or nuchal translucency screening
Sugar Babies Study Sugar Babies ACTRN12608000623392 Newborn Intensive Care, Waikato Hospital, Hamilton Dr Deborah Harrris: deborah.harris@waikatodhb.health.nz Recruitment complete
Improving oral hygiene to reduce the risk of preterm birth: A randomised controlled trial assessing a high intensity educational intervention ACTRN12605000767606 caroline.crowther@adelaide.edu.au Discontinued Preterm birth ? prevention and treatment Women with a singleton pregnancy
HUNTER trial - High-flow nasal cannulae use in non-tertiary centres for early respiratory distress in newborn infants ACTRN12614001203640 Dr Brett Manley, Newborn Research Centre, The Royal Women's Hospital, Parkville, VIC Currently recruiting Neonatology, Respiratory Distress, Preterm Infants, CPAP
Preterm and term infants admitted to non-tertiary nurseries with respiratory distress
The influence of acupuncture on the induction of labour for women with a post date pregnancy: a randomised controlled trial. PT0348 / ACTRN12606000494538 caroline.smith@uws.edu.au Recruitment complete Labour and intrapartum care Women > or = 41 weeks; singleton pregnancy; cephalic presentation
MONT (mask or nasal tube) Trial: A randomised controlled trial of mask versus nasal tube for the stabilisation of preterm infants (born between 24 and 29 complete weeks gestation) in the delivery room ACTRN12610000230055; NTR2061 Newborn Services and Neonatal Research, Royal Women's Hospital Omar Kamlin Recruitment complete Newborn resuscitation
Expulsion of a retained placenta using acupuncture: a randomised controlled trial PT0347 caroline.smith@uws.edu.au Recruitment complete Labour and intrapartum care
Adding negative pRESSure to improve healING (the DRESSING trial) ACTRN12615000286549 NHMRC Centre for Research Excellence in Nursing (NCREN), Centre for Health Practice Innovation (HPI), Menzies Health Institute Qld (MHIQ), GRIFFITH UNIVERSITY, Gold Coast Campus b.gillespie@griffith.edu.au Currently recruiting Caesarean section, Negative pressure wound therapy, Surgical site infection Pregnant women with BMI ≥30, undergoing Caesarean section
Routine neonatal postextubation chest physiotherapy: A randomized controlled trial Catherine Bagley Recruitment complete
APTS - Australian Placental Transfusion Study NHMRC571309; ACTRN12610000633088 NHMRC Clinical Trials Centre, The University of Sydney, NSW apts@ctc.usyd.edu.au Recruitment complete
PROVIDE - Impact of Protein IVN on Development: for extremely low birthweight babies, does higher intravenous protein intake in the first 5 days after birth improve neurodevelopmental outcome, growth and body composition through to 2 years of age? ACTRN12612001084875 Liggins Institute, University of Auckland, Barbara Cormack bcormack@adhb.govt.nz Currently recruiting
IMPACT reviewed
Protein, intravenous nutrition, neurodevelopment Birthweight <1000 g
MBM - My Baby’s Movements: a stepped wedge cluster randomised controlled trial to raise maternal awareness of fetal movements during pregnancy ACTRN12614000291684 Mater Research Institute - The University of Queensland u.chandrasiri@mater.uq.edu.au Not yet recruiting
IMPACT endorsed
Stillbirth prevention. Fetal surveillance. Parental social and emotional wellbeing. Pregnant women without any congenital abnormalities
STRIDER (NZAus)- A randomised placebo-controlled trial of a new therapy (sildenafil) to help growth in severely growth restricted fetuses at very early gestations ACTRN12612000584831 Department of Obstetrics and Gynaecology, University of Auckland Laura Mackay (Trial Manager) laura.mackay@auckland.ac.nz; Dr Katie Groom (Chief Investigator) k.groom@auckland.ac.nz Recruitment complete
IMPACT reviewed
Fetal growth. Preeclampsia. Pterterm birth - prevention and treatment Women with pregnancies complicated early onset fetal growth restriction. Abdominal circumference ≤3rd centile at 22-28 weeks or EFW <700g at 28-80 weeks
LIFT - Lactoferrin Infant Feeding Trial to prevent sepsis and death in preterm infants ACTRN12611000247976 NHMRC Clinical Trial Centre, NSW

lift@ctc.usyd.edu.au
Currently recruiting
IMPACT reviewed
MAGENTA - Does antenatal magnesium sulphate given to women at risk of preterm birth between 30 and 34 weeks' gestation reduce the risk of death or cerebral palsy in their children? - a randomised controlled trial. ACTRN126110000491965 University of Adelaide, Clinical Trial Manager Pat Ashwood +61 8 8161 7767
Currently recruiting
IMPACT reviewed
Neuroprotection, Antenatal magnesium sulphate, Cerebral palsy
Women at risk of preterm birth between 30 and 34 weeks’ gestation where birth is planned or definitely expected within 24 hours, have a singleton or twin pregnancy, no contraindications to the use of antenatal magnesium sulphate
PAEAN - Preventing Adverse Outcomes of Neonatal Hypoxic Ischaemic Encephalopathy with Erythropoietin: a randomised placebo controlled multicentre clinical trial ACTRN12614000669695 NHMRC Clinical Trials Centre, University of Sydney

paean@ctc.usyd.edu.au

+61 2 9562 5000

Currently recruiting
IMPACT reviewed
Newborn – developmental
DIAMOND - DIfferent Approaches to MOderate & later preterm Nutrition: Determinants of feed tolerance, body composition and development ACTRN12616001199404 Liggins Institute, University of Auckland
t.alexander@auckland.ac.nz
Currently recruiting
IMPACT endorsed
Newborn nutrition Newborn body composition Neurodevelopment Preterm babies between 32+0 - 35+6 admitted to the neonatal unit requiring IV insertion
EPPI Trial - Enoxaparin for the Prevention of Preeclampsia and Intrauterine growth restriction ? a pilot randomised placebo-controlled trial ACTRN12609000699268 Department of Obstetrics and Gynaecology, University of Auckland. Laura Mackay (Trial Manager) laura.mackay@auckland.ac.nz; Dr Katie Groom (Chief Investigator) k.groom@auckland.ac.nz Recruitment complete
IMPACT reviewed
Fetal growth. Preeclampsia Women with previous pregnancy complicated by early onset preeclampsia or fetal growth restriction
POP-OUT - Persistent Occiput Posterior: OUTcomes following manual rotation ACTRN12612001312831 Royal Prince Alfred Hospital, NSW hala.phipps@email.cs.nsw.gov.au Recruitment complete
IMPACT reviewed
Labour and intrapartum care
PROTECT - Can Pentoxifylline improve long-term outcomes in preterm infants with late-onset sepsis or necrotizing enterocolitis? A pragmatic, randomized, controlled trial ACTRN12616000405415 NHMRC Clinical Trial Centre, NSW
protect@ctc.usyd.edu.au

Currently recruiting
IMPACT reviewed
Preterm infant sepsis and inflammation, neurodevelopment Born at less than 29 weeks gestational age with suspected late-onset sepsis or necrotizing enterocolitis
CIRCA DIEM ACTRN12618000371291p Jane Pillow
+61417621960
jane.pillow@uwa.edu.au
The University of Western Australia
Not yet recruiting
IMPACT endorsed
Newborn – developmental
Babies born at < 31 weeks and 6 days postmenstrual age. Have initial care at a perinatal centre where routine care does not include individual environmental light/noise cycling.
The PROTECT Me trial RES-17-0000-583A Monash Medical Centre Clayton
Dr Kirsten Palmer
kirsten.palmer@monash.edu
Currently recruiting
IMPACT endorsed
Early onset Intrauterine Fetal Growth Restriction Women with pregnancies complicated by severe fetal growth restriction between 23+0 and 31+6 weeks gestation